Biolase (BIOL) Reports In-Line Q1 EPS

Biolase (NASDAQ: BIOL) reported Q1 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $10 million versus the consensus estimate of $10.96 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• United Natural Foods (UNFI) Reports In-Line Q3 EPS ; Offers Outlook
• Lands' End (LE) Tops Q1 EPS by 8c ; Offers Guidance